AFT Pharmaceuticals Ltd AFT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- NZ$4.30
- Day Range
- NZ$4.33–4.38
- 52-Week Range
- NZ$2.80–4.85
- Bid/Ask
- NZ$4.32 / NZ$4.38
- Shares Outstanding
- 104.87M
- Market Cap
- NZ$454.07M
- Volume/Avg
- 17,548 / 35,288
Key Statistics
- Price/Earnings (Normalized)
- 30.77
- Price/Sales
- 1.81
- Dividend Yield (Trailing)
- 0.58%
- Dividend Yield (Forward)
- 0.58%
- Dividend Payment Schedule
- Jul
- Total Yield
- 0.58%
Company Profile
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Maxigesic dose forms, Capsaicin creams, Crystaderm, Kiwisoothe, Micolette, and others. The group has four operating segments based on geographical location being Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia, which includes the sales and distribution activity relating to the Australian market.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 97
- Website
- https://www.aftpharm.com
Valuation
|
Metric
|
AFT
|
|---|---|
Price/Earnings (Normalized) | 30.77 |
Price/Book Value | 4.12 |
Price/Sales | 1.81 |
Price/Cash Flow | — |
Price/Earnings
AFT
Financial Strength
|
Metric
|
AFT
|
|---|---|
Quick Ratio | 1.03 |
Current Ratio | 2.24 |
Interest Coverage | 9.83 |
Quick Ratio
AFT
Profitability
|
Metric
|
AFT
|
|---|---|
Return on Assets (Normalized) | 7.58% |
Return on Equity (Normalized) | 13.79% |
Return on Invested Capital (Normalized) | 11.10% |
Return on Assets
AFT
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|Xmw&#!?s | LOCK|!<htZ | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|pFCRp&rw | LOCK|Bm%j# | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|dDzx!!< | LOCK|Nd! | $39B | |||
| Zoetis Inc Class A
ZTS
| LOCK|p<gk%q<J | LOCK|!m^ | $30B | |||
| Viatris Inc
VTRS
| LOCK|N@yHYZ | LOCK|Dr | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|SpM | LOCK|P%# | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|$@<H^Z | LOCK|X! | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|c!nV#z! | LOCK|fs? | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|!MTCk$ | LOCK|Fr>y! | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|h>#cnH% | LOCK|Xp | $2B |
United States